Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Cancer Management and Research|March 6, 2025
Drug Repurposing in Pancreatic Cancer: A Multi-Stakeholder Perspective to Improve Treatment Options for Pancreatic Cancer PatientsEvelyn Hewitt, Gauthier Bouche, Alexandre Costa Alencar, et al.
Frontiers in Cell and Developmental Biology|October 5, 2020
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of ResistanceFederica Iannelli, Andrea Ilaria Zotti, Maria Serena Roca, et al.
Communications Chemistry|March 22, 2024
Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumorsStefano Cinti, Stefano Tomassi, Chiara Ciardiello, et al.
BMC Medicine|January 8, 2023
Recommendations for robust and reproducible preclinical research in personalised medicineVibeke Fosse, Emanuela Oldoni, Florence Bietrix, et al.
International Journal of Molecular Sciences|November 27, 2024
ICOSLG Is Associated with Anti-PD-1 and Concomitant Antihistamine Treatment Response in Advanced MelanomaDomenico Mallardo, Mario Fordellone, Margaret Ottaviano, et al.
Journal of Translational Medicine|October 26, 2023
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimabDomenico Mallardo, Rachel Woodford, Alexander M Menzies, et al.
BMC Cancer|September 19, 2024
Randomized phase 2 study of valproic acid combined with simvastatin and gemcitabine/nab-paclitaxel-based regimens in untreated metastatic pancreatic adenocarcinoma patients: the VESPA trial study protocolAlfredo Budillon, Alessandra Leone, Eugenia Passaro, et al.
Journal of Translational Medicine|September 30, 2022
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarizationDomenico Mallardo, Ester Simeone, Vito Vanella, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 6, 2024
Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cellsAngela Filograna, Stefano De Tito, Matteo Lo Monte, et al.
Journal of Translational Medicine|July 24, 2019
Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy)Paolo A Ascierto, Sanjiv S Agarwala, Gerardo Botti, et al.
Pageof 16